Filing Details
- Accession Number:
- 0001127602-19-014154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-02 16:24:04
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-02 16:24:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1745856 | D Robert Auerbach | C/O The Cooper Companies, Inc. 6140 Stoneridge Mall Road, Suite 590 Pleasanton CA 94588 | President, Csi | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-01 | 2,416 | $131.60 | 4,954 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-04-01 | 2,046 | $175.31 | 7,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-04-01 | 864 | $229.66 | 7,864 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-01 | 5,326 | $300.00 | 2,538 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-01 | 2,416 | $0.00 | 2,416 | $131.60 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-01 | 2,046 | $0.00 | 2,046 | $175.31 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-04-01 | 864 | $0.00 | 864 | $229.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,416 | 2025-12-09 | No | 4 | M | Direct | |
| 3,067 | 2026-12-13 | No | 4 | M | Direct | |
| 3,454 | 2027-12-12 | No | 4 | M | Direct |
Footnotes
- 12/9/15 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/9/16; 1/5 shall vest on 12/9/17; 1/5 shall vest on 12/9/18; 1/5 shall vest on 12/9/19 and 1/5 shall vest on 12/9/20.
- 12/13/16 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/17; 1/5 shall vest on 12/13/18; 1/5 shall vest on 12/13/19; 1/5 shall vest on 12/13/20 and 1/5 shall vest on 12/13/21.
- 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant.
Billionaire Hedge Funds
